SCHEMBL30879136

SCHEMBL30879136

COc1cccc(Nc2ncc3c(C#C[Si](C(C)C)(C(C)C)C(C)C)c(-c4ccccc4Cl)c(=O)n(C)c3n2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 10/20 0.59
EGFR P00533 9/20 0.59
WEE1 P30291 5/20 0.54
USP2 O75604 6/20 0.51
CYP1A2 P05177 6/20 0.51
CLK4 Q9HAZ1 3/20 0.51
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
CASP1 P29466 3/20 0.50
CASP7 P55210 3/20 0.50
LMNA P02545 3/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP3A4 P08684 1/20 0.50
SRC P12931 5/20 0.49
CYP2C9 P11712 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MAPK1 P28482 1/20 0.48
FGFR2 P21802 3/20 0.47
FGFR4 P22455 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878861 0.90 WEE1 (0.67) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL30878366 0.89 FGFR1 (0.66) FGFR1EGFRWEE1USP2CYP1A2
SCHEMBL30878805 0.87 EGFR (0.56) FGFR1EGFRWEE1SRCLCK
SCHEMBL30879263 0.87 ABL1 (0.59) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL30879194 0.82 WEE1 (0.62) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL30878742 0.81 SRC (0.58) FGFR1WEE1CYP3A4SRCFGFR2
SCHEMBL30878753 0.81 SRC (0.58) FGFR1WEE1CYP3A4SRCFGFR2
SCHEMBL30878358 0.81 FGFR1 (0.64) FGFR1EGFRWEE1USP2CYP1A2
SCHEMBL30878665 0.80 WEE1 (0.49) FGFR1EGFRWEE1SRCFGFR2
SCHEMBL30879233 0.80 WEE1 (0.52) FGFR1EGFRWEE1SRCFGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed